title: Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnover.
abstract: Clinical and laboratory studies of two siblings, both suffering from gray platelet syndrome (GPS) are described. The patients had a mild bleeding disorder, their platelets were blue-gray in panoptic stains, and alpha-granules were markedly reduced, as shown by electron microscopy. The platelet content of platelet factor 4 and that of beta-thromboglobulin were significantly reduced (3%-7% of normal). Platelet count was decreased (33-150 X 10(9)/1) and small platelets were increased in platelet volume distribution. Bleeding time was prolonged on most occasions. Bone marrow aspiration was performed in one patient and revealed increased reticulin fibers, however, megakaryocyte count was normal. The mean platelet survival was 4.8 days using 111indium-labelled platelets. In this patient, platelet-associated IgG was within the normal range. Prednisone therapy failed to increase platelet count. Dental surgery was performed under cover of desmopressin and no bleeding complication occurred; however, no improvement of bleeding time was observed. The patient delivered a healthy male infant without hemorrhaging while under concurrent platelet transfusion therapy.
authors.forename: M
authors.initials: M
authors.lastname: Köhler
authors.forename: P
authors.initials: P
authors.lastname: Hellstern
authors.forename: E
authors.initials: E
authors.lastname: Morgenstern
authors.forename: C
authors.initials: C
authors.lastname: Mueller-Eckhardt
authors.forename: R
authors.initials: R
authors.lastname: Berberich
authors.forename: R J
authors.initials: RJ
authors.lastname: Meiser
authors.forename: P
authors.initials: P
authors.lastname: Scheffler
authors.forename: E
authors.initials: E
authors.lastname: Wenzel
mesh_terms: D000328:Adult; D001778:Blood Coagulation Disorders / Q000097:blood* / Q000150:complications; D001792:Blood Platelets / Q000378:metabolism* / Q000648:ultrastructure; D001856:Bone Marrow Examination; D003594:Cytoplasmic Granules / Q000473:pathology*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D006472:Oral Hemorrhage / Q000517:prevention & control; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000172:deficiency; D013921:Thrombocytopenia / Q000097:blood* / Q000209:etiology / Q000473:pathology; D001620:beta-Thromboglobulin / Q000172:deficiency
chemical_list: D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D003894:Deamino Arginine Vasopressin